The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease

Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730  PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In […]